期刊文献+

混合实验法优化含胆固醇微乳处方 被引量:4

Mixed experiment method for optimization of cholesterol-involved microemulsion prescription
下载PDF
导出
摘要 目的考察卵磷脂与胆盐作为混合表面活性剂制备含胆固醇微乳液的可行性,并对微乳处方进行优化。方法采用混合实验法筛选微乳处方,以表面活性剂、助表面活性剂和油作为自变量,粒径作为因变量,用数学方程和效应曲线表示自变量与因变量的关系,据此优化微乳处方,并对微乳液的物理稳定性初步进行判定。结果优化的微乳平均粒径为19.12 nm,多分散指数(PDI)平均值为0.153,物理稳定性良好。结论卵磷脂与胆盐可作为表面活性剂制备含胆固醇微乳,混合实验法能够客观地优化微乳处方,优化的微乳粒径分布均匀,性质稳定。 Objective To explore the possibility of using lecithin and cholate as surfactant to prepare cholesterol-involved microemulsion (ME) prescription, and optimize this ME prescription. Methods The mixed experiment method was applied to screen ME prescription. With surfactant, cosurfactant and oil as independent variable, grain diameter as dependent variable, mathematical equations and effect curve were used to show the relation between independent and dependent variable. Besides, according to this optimized ME prescription, its preliminary physical stability was evaluated. Results The optimized average grain diameter of ME was 19.12 nm, the average polydispersity Index(PDI) was 0.153, indicating superior physical stability. Conclusion The lecithin and cholate could be used as surfactant to prepare cholesterol-involved ME. The mixed experiment method could objectively optimize ME prescription, in which grain diameter of ME has uniform distribution and stable quality.
机构地区 北京中医药大学
出处 《北京中医药》 2013年第4期304-307,共4页 Beijing Journal of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(81102815) 教育部博士点新教师基金(20110013120017) 北京中医药大学自主选题(2011-MZYY-07) 北京中医药大学可获取的人体诊断信息关键技术创新团队(2011-CXTD-05)
关键词 卵磷脂 胆盐 胆固醇 微乳 混合实验法 lecithin cholate cholesterol microemulsion mixed experiment method
  • 相关文献

参考文献11

  • 1VYAS TK, Babbar AK,Sharma RK,et al.Intranasal mucoadhesive microemulsions of clonazepam:preliminary studies on brain targeting[J].Pharm Sci, 2006,95 : 570-580.
  • 2Ammon CS,Shafir B.Transdermal drug delivery using microemulsion and aqueous systems: Influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems [J].Int J Pharm, 2006,311: 55-62.
  • 3叶海英,张忠义.常见载药微乳制剂及其特性[J].南方医科大学学报,2001,25(S1):80-83. 被引量:5
  • 4张奕,蒋新国.鼻腔给药系统的鼻粘膜毒性及解决途径[J].中国医药工业杂志,2001,32(7):323-327. 被引量:45
  • 5寇欣.微乳给药系统的研究进展[J].天津药学,2005,17(6):49-52. 被引量:24
  • 6Von Co,want C,Tbore PN,Engstro SM.Triglyceridebased mieroemulsion for intravenous administration of spar-ingly soluble substanees[J].Pharm Sei, 1998,87 (2) :200.
  • 7Lee JM,Park KM,Lim S J, et al.Microemulsion formulation of clonixic acid:solubility enhancement and pain reduction [J].Pharm Pharmacol, 2002,54( 1 ) : 43.
  • 8张莉,向东,洪诤,张志荣.肝靶向去甲斑蝥素微乳的研究[J].药学学报,2004,38(8):650-655. 被引量:52
  • 9Muller K.Structural dimorphism of bile salecithin mixed micelles a possible regulatory mechanism for cholesterol solubility in bile X-ray structure analysis [J].Biochemistry, 1981,20(2) :404-414.
  • 10Spernatha A, Aserina A, Zisermanb L, et al. Phosphatidylcholine embedded microemulsions:Physical properties and improved Caco-2 cell permeability [J]. J Controlled Release, 2007,119(3 ) : 279-290.

二级参考文献69

共引文献115

同被引文献23

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部